Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

CRXTQ CLARUS THERAPEUTICS HLDGS INC

Watchlist
0.035
+0.005+16.67%
Close 12/01 16:00 ET
High
0.043
Open
0.030
Turnover
2.02K
Low
0.030
Pre Close
0.030
Volume
53.60K
Market Cap
1.82M
P/E(TTM)
Loss
52wk High
0.065
Shares
52.02M
P/E(Static)
Loss
52wk Low
0.013
Float Cap
1.26M
Bid/Ask %
0.00%
Historical High
0.065
Shs Float
35.92M
Volume Ratio
0.07
Historical Low
0.013
Dividend TTM
--
Div Yield TTM
--
P/B
-0.14
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.15%
Amplitude
44.33%
Avg Price
0.037
Lot Size
1
Float Cap
1.26M
Bid/Ask %
0.00%
Historical High
0.065
Shs Float
35.92M
Volume Ratio
0.07
Historical Low
0.013
Dividend TTM
--
P/B
-0.14
Dividend LFY
--
Turnover Ratio
0.15%
Amplitude
44.33%
Avg Price
0.037
Lot Size
1
Price Forecast

No Data

News

Comment

No More
Company Overview More
Clarus Therapeutics Holdings, Inc. is a pharmaceutical company, which engages in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications. The company was founded in 2004 and is headquartered in Los Angeles, CA.
CEO: Dr. Robert E. Dudley
Market: Pink Market
Listing Date: 02/09/2021
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist